| 1 | Survival and quality of life analysis in glioblastoma multif… (10.5603/rpor.a2022.0113) | Abstract References ORCID License | 222.79 | 168 |
| 2 | FLASH radiotherapy: an emerging approach in radiation therap… (10.5603/rpor.a2022.0038) | Abstract References ORCID License | 187.51 | 74 |
| 3 | T1-weighted and T2-weighted MRI image synthesis with convolu… (10.5603/rpor.a2021.0005) | Abstract References ORCID License | 178.53 | 60 |
| 4 | A small case series about safety and effectiveness of a hypo… (10.5603/rpor.a2021.0013) | Abstract References ORCID License | 144.72 | 27 |
| 5 | Radiation-induced skin injury in the head and neck region: p… (10.5603/rpor.100775) | Abstract References ORCID License | 139.79 | 24 |
| 6 | High-intensity aerobic interval training and resistance trai… (10.5603/rpor.a2022.0036) | Abstract References ORCID License | 138.02 | 23 |
| 7 | Proton re-irradiation of unresectable recurrent head and nec… (10.5603/rpor.a2021.0029) | Abstract References ORCID License | 134.24 | 21 |
| 8 | Commissioning and quality assurance of HalcyonTM 2.0 linear… (10.5603/rpor.a2021.0065) | Abstract References ORCID License | 130.10 | 19 |
| 9 | Special stereotactic radiotherapy techniques: procedures and… (10.5603/rpor.a2021.0129) | Abstract References ORCID License | 127.88 | 18 |
| 10 | Radiation-induced lung injury — what do we know in the era o… (10.5603/rpor.a2022.0046) | Abstract References ORCID License | 127.88 | 18 |
| 11 | Pretreatment CT and PET Radiomics Predicting Rectal Cancer P… (10.5603/rpor.a2021.0004) | Abstract References ORCID License | 125.53 | 17 |
| 12 | Real-time measurement of ICD lead motion during stereotactic… (10.5603/rpor.a2021.0020) | Abstract References ORCID License | 125.53 | 17 |
| 13 | Radiobiology of stereotactic radiotherapy (10.5603/rpor.a2022.0005) | Abstract References ORCID License | 125.53 | 17 |
| 14 | Prehabilitation approaches for gastrointestinal cancer surge… (10.5603/rpor.103136) | Abstract References ORCID License | 123.04 | 16 |
| 15 | Deep inspiration breath hold in post-operative radiotherapy… (10.5603/rpor.a2022.0085) | Abstract References ORCID License | 120.41 | 15 |
| 16 | Glioblastoma — treatment and obstacles (10.5603/rpor.a2022.0076) | Abstract References ORCID License | 117.61 | 14 |
| 17 | Deep inspiration breath hold: dosimetric benefits to decreas… (10.5603/rpor.a2023.0027) | Abstract References ORCID License | 117.61 | 14 |
| 18 | Evaluation of patient organ doses from kilovoltage cone-beam… (10.5603/rpor.a2021.0038) | Abstract References ORCID License | 114.61 | 13 |
| 19 | Radiosensitization effects by bismuth oxide nanorods of diff… (10.5603/rpor.a2021.0094) | Abstract References ORCID License | 111.39 | 12 |
| 20 | The prognostic value of red cell distribution width (RDW), n… (10.5603/rpor.a2021.0126) | Abstract References ORCID License | 111.39 | 12 |
| 21 | Primary cancer-associated fibroblasts exhibit high heterogen… (10.5603/rpor.a2023.0026) | Abstract References ORCID License | 111.39 | 12 |
| 22 | An omics-based tumor microenvironment approach and its prosp… (10.5603/rpor.102823) | Abstract References ORCID License | 107.92 | 11 |
| 23 | Targeted nanodelivery systems for personalized cancer therap… (10.5603/rpor.103524) | Abstract References ORCID License | 107.92 | 11 |
| 24 | A radiobiological perspective on radioresistance or/and radi… (10.5603/rpor.99355) | Abstract References ORCID License | 107.92 | 11 |
| 25 | The LabBM score is an excellent survival prediction tool in… (10.5603/rpor.a2021.0096) | Abstract References ORCID License | 107.92 | 11 |
| 26 | Hybrid split-arc partial-field volumetric modulated arc ther… (10.5603/rpor.a2022.0022) | Abstract References ORCID License | 107.92 | 11 |
| 27 | Midsize noncoding RNAs in cancers: a new division that clari… (10.5603/rpor.a2022.0123) | Abstract References ORCID License | 107.92 | 11 |
| 28 | Radiotherapy for locally advanced head and neck cancer in el… (10.5603/rpor.a2021.0002) | Abstract References ORCID License | 104.14 | 10 |
| 29 | Chemoradiotherapy or chemotherapy as adjuvant treatment for… (10.5603/rpor.a2021.0040) | Abstract References ORCID License | 104.14 | 10 |
| 30 | Hypofractionated radiotherapy in breast cancer: a 10-year si… (10.5603/rpor.a2021.0109) | Abstract References ORCID License | 104.14 | 10 |
| 31 | Vertebral hemangioma — the current radiation therapy perspec… (10.5603/rpor.a2023.0009) | Abstract References ORCID License | 104.14 | 10 |
| 32 | Biological role and diagnostic utility of ribosomal protein… (10.5603/rpor.a2023.0030) | Abstract References ORCID License | 104.14 | 10 |
| 33 | Spine Patient Optimal Radiosurgery Treatment for Symptomatic… (10.5603/rpor.a2023.0037) | Abstract References ORCID License | 104.14 | 10 |
| 34 | Therapeutic efficacy of rifaximin loaded tamarind gum polysa… (10.5603/rpor.a2021.0100) | Abstract References ORCID License | 100.00 | 9 |
| 35 | Stereotactic radiotherapy for liver oligometastases (10.5603/rpor.a2021.0130) | Abstract References ORCID License | 100.00 | 9 |
| 36 | Computational simulations establish a novel transducer array… (10.5603/rpor.a2021.0132) | Abstract References ORCID License | 100.00 | 9 |
| 37 | Stereotactic radiotherapy for oligometastases in the lymph n… (10.5603/rpor.a2022.0007) | Abstract References ORCID License | 100.00 | 9 |
| 38 | AlignRT®, Catalyst™ and RPM™ in locoregional radiotherapy of… (10.5603/rpor.a2022.0097) | Abstract References ORCID License | 100.00 | 9 |
| 39 | Gene polymorphisms and risk of head and neck squamous cell c… (10.5603/rpor.a2022.0115) | Abstract References ORCID License | 100.00 | 9 |
| 40 | Application of 3D printing for personalized boluses in radio… (10.5603/rpor.104014) | Abstract References ORCID License | 95.42 | 8 |
| 41 | A radiobiological comparison of hypo-fractionation versus co… (10.5603/rpor.a2021.0015) | Abstract References ORCID License | 95.42 | 8 |
| 42 | Feasibility and potential advantages using VMAT in SRS metas… (10.5603/rpor.a2021.0019) | Abstract References ORCID License | 95.42 | 8 |
| 43 | A comparative analysis of Acuros XB and the analytical aniso… (10.5603/rpor.a2021.0050) | Abstract References ORCID License | 95.42 | 8 |
| 44 | Dosimetric comparison of normal breathing and deep inspirati… (10.5603/rpor.a2021.0124) | Abstract References ORCID License | 95.42 | 8 |
| 45 | Intensity-modulated radiotherapy for the management of prima… (10.5603/rpor.a2023.0022) | Abstract References ORCID License | 95.42 | 8 |
| 46 | First reported case of concurrent sonidegib and radiotherapy… (10.5603/rpor.a2021.0010) | Abstract References ORCID License | 90.31 | 7 |
| 47 | Dosimetric predictors of acute bone marrow toxicity in carci… (10.5603/rpor.a2021.0039) | Abstract References ORCID License | 90.31 | 7 |
| 48 | Change in dysphagia and laryngeal function after radical rad… (10.5603/rpor.a2021.0078) | Abstract References ORCID License | 90.31 | 7 |
| 49 | Stereotactic radiotherapy for adrenal oligometastases (10.5603/rpor.a2021.0104) | Abstract References ORCID License | 90.31 | 7 |
| 50 | Stereotactic radiotherapy for spinal hemangioblastoma — dise… (10.5603/rpor.a2022.0003) | Abstract References ORCID License | 90.31 | 7 |